Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Apr 14, 1998
New Brunswick, NJ (April 14, 1998) -- Johnson & Johnson today announced sales of $5.8 billion and net earnings of $1.0 billion for the first quarter of 1998, increases of 1.2% and 11.1% respectively over 1997 first-quarter results. Diluted earnings per share for the first quarter were $.73, up 10.6% from the same period in 1997. Basic earnings per ...
Apr 23, 1998
New Brunswick, NJ (April 23, 1998) -- Johnson & Johnson today announced that its Board of Directors has declared a 13.6% increase in the quarterly dividend rate, from $0.22 cents per share to $0.25 cents per share. The increase was announced this morning at the Annual Shareowners Meeting in New Brunswick, NJ. "In recognition of our strong financi...
Jul 14, 1998
New Brunswick, NJ (July 14, 1998) -- Johnson & Johnson today announced sales of $5.8 billion and net earnings of $1.0 billion for the second quarter of 1998, increases of 1.5% and 10.6% respectively over 1997 second quarter results. Diluted earnings per share for the second quarter were $.74, up 10.4% from the same period in 1997. The impact of the...
Oct 13, 1998
New Brunswick, NJ (October 13, 1998) -- Johnson & Johnson today announced sales of $5.7 billion and net earnings of $961 million for the third quarter of 1998, increases of 2.5% and 12.4%, respectively, over 1997 third quarter results. Diluted earnings per share for the third quarter were $.70, up 11.1% from the same period in 1997. The impact of t...
Jan 26, 1999
New Brunswick, NJ (January 26, 1999) -- Johnson & Johnson today announced sales for the fourth quarter of 1998 of $6.4 billion, an increase of 13.1% over sales of $5.6 billion for the same period last year. Domestic sales were up 14.2% while international sales increased 11.8%. Worldwide sales for the year 1998 were $23.7 billion, an increase of ...
Apr 20, 1999
New Brunswick, NJ (April 20, 1999) -- Johnson & Johnson today announced sales of $6.6 billion and net earnings of $1.1 billion for the first quarter of 1999, increases of 14.8% and 11.7%, respectively, over 1998 first-quarter results. Diluted earnings per share for the first quarter were $.82, up 12.3% from the same period in 1998. The impact of th...
Jul 19, 1999
NEW BRUNSWICK, N.J., July 19 -- Leo F. Mullin today was elected to the Board of Directors of Johnson & Johnson (NYSE: JNJ), the world's leading health care corporation. Mr. Mullin is president, chief executive officer and a director of Delta Air Lines. Prior to joining Delta in 1997, Mr. Mullin served as vice chairman of Unicom Corporation...
Jul 20, 1999
NEW BRUNSWICK, N.J., July 20-- Johnson & Johnson (NYSE: JNJ) today announced record sales of $6.9 billion and record net earnings of $1.2 billion for the second quarter of 1999, increases of 18.5% and 14.9%, respectively, over 1998 second-quarter results. Diluted earnings per share for the second quarter were $.84, up 13.5% from the same period in ...
Sep 7, 1999
NEW BRUNSWICK, N.J. and MALVERN, Pa., Sept. 7 -- Johnson & Johnson (NYSE: JNJ), the worldwide manufacturer of health care products, and Centocor, Inc. (Nasdaq: CNTO), a leader in monoclonal antibody technology and acute vascular care and immunology products, today announced that concerning their planned merger, the Securities and Exchange Commissio...
Oct 5, 1999
NEW BRUNSWICK, N.J. and MALVERN, Pa., Oct. 5 -- Johnson & Johnson (NYSE: JNJ), the worldwide manufacturer of health care products, and Centocor, Inc. (Nasdaq: CNTO), a leader in monoclonal antibody technology and acute vascular care and immunology products, today announced the stock-for-stock exchange ratio for their previously announced definitive...
Page:
1
... NextLast
= add release to Briefcase